Apexium Financial’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.72M | Sell |
13,625
-3,082
| -18% | -$390K | 0.09% | 90 |
|
|
2025
Q1 | $2.14M | Buy |
16,707
+6,667
| +66% | +$853K | 0.13% | 82 |
|
|
2024
Q4 | $1.33M | Buy |
10,040
+7,919
| +373% | +$1.05M | 0.08% | 89 |
|
|
2024
Q3 | $309K | Buy |
2,121
+209
| +11% | +$30.4K | 0.02% | 185 |
|
|
2024
Q2 | $262K | Sell |
1,912
-57
| -3% | -$7.82K | 0.02% | 193 |
|
|
2024
Q1 | $270K | Sell |
1,969
-254
| -11% | -$34.9K | 0.02% | 190 |
|
|
2023
Q4 | $302K | Buy |
2,223
+82
| +4% | +$11.1K | 0.02% | 217 |
|
|
2023
Q3 | $262K | Sell |
2,141
-632
| -23% | -$77.3K | 0.03% | 183 |
|
|
2023
Q2 | $352K | Sell |
2,773
-134
| -5% | -$17K | 0.03% | 162 |
|
|
2023
Q1 | $375K | Sell |
2,907
-7
| -0.2% | -$904 | 0.04% | 152 |
|
|
2022
Q4 | $383K | Hold |
2,914
| – | – | 0.04% | 146 |
|
|
2022
Q3 | $341K | Buy |
+2,914
| New | +$341K | 0.04% | 145 |
|
|
2021
Q4 | – | Sell |
-1,428
| Closed | -$231K | – | 98 |
|
|
2021
Q3 | $231K | Hold |
1,428
| – | – | 0.13% | 82 |
|
|
2021
Q2 | $234K | Buy |
1,428
+16
| +1% | +$2.62K | 0.15% | 72 |
|
|
2021
Q1 | $213K | Buy |
1,412
+54
| +4% | +$8.15K | 0.16% | 73 |
|
|
2020
Q4 | $206K | Sell |
1,358
-151
| -10% | -$22.9K | 0.16% | 71 |
|
|
2020
Q3 | $202K | Buy |
+1,509
| New | +$202K | 0.16% | 66 |
|